← Back to Patent Explorer
US4587118A Expired / Lapsed US ⏱️ 0.0 years remaining

Dry sustained release theophylline oral formulation

Assignee: Key Pharmaceuticals Inc
•
Filing: 1984-12-12
•
Granted: 1986-05-06
•
Expires: 2004-12-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dry sustained release oral dosage formulation of theophylline and a method of orally administering theophylline is disclosed. The oral formulation is comprised of a capsule which includes upper and lower parts which are connectible and easily separable from each other, and a plurality of micropellets present in the capsule. The micropellets provide sustained release of theophylline when taken by a patient and are comprised of inner seeds coated with a mixture of theophylline and polyvinylpyrrolidone which is further coated with a mixture of ethylcellulose and hydroxypropylcellulose. The oral dosage formulation is administered by separating the upper and lower parts of the capsule and placing the micropellets on a food which is preferably soft to the extent of not requiring chewing and then eating the food with the micropellets thereon. The micropellets have sufficient size so that they can be seen, but are sufficiently small so that they are not easily detected in the mouth in combination with the food and can be swallowed without difficulty.

Inventors

  • 👤 Chiin H. Hsiao

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 16:18
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/52

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 82 words
A sustained release dosage formulation of theophylline which includes an easily openable capsule having therein a plurality of micropellets, the sum of such micropellets in said capsule forming a dosage unit of theophylline, each of said micropellets being based upon a seed having coated thereon a first coating mixture of theophylline and polyvinylpyrrolidone, characterized in that the thus coated seed has further coated thereon a second coating mixture of about 90-70% by weight of ethylcellulose and about 10-30% by weight of hydroxypropylcellulose.
Claim 2
Dependent Claim 82 words
A sustained release dosage formulation of theophylline which includes an easily openable capsule having therein a plurality of micropellets, the sum of such micropellets in said capsule forming a dosage unit of theophylline, each of said micropellets being based upon a seed having coated thereon a first coating mixture of theophylline and polyvinylpyrrolidone, characterized in that the thus coated seed has further coated thereon a second coating mixture of about 90-70% by weight of ethylcellulose and about 10-30% by weight of hydroxypropylcellulose.
Claim 3
Dependent Claim 31 words
The dosage formulation of claim 1 further characterized in that the weight of the second coating mixture is about 5-10% of the weight of the micropellets before such coating is applied.
Claim 4
Dependent Claim 25 words
The dosage formulation of claim 1 further characterized in that the second coating mixture contains about 3 parts of ethylcellulose to 1 part of hydroxypropylcellulose.
Claim 5
Dependent Claim 22 words
The dosage formulation of claim 1 further characterized in that said polyvinylpyrrolidone has a molecular weight of about 30,000 to about 50,000.
Claim 6
Dependent Claim 19 words
The dosage formulation of claim 4 further characterized in that said polyvinylpyrrolidone has a molecular weight of about 40,000.
Claim 7
Dependent Claim 20 words
The dosage formulation of claim 1 further charcterized in that said seed is sugar having a mesh size of 60/80.
Claim 8
Dependent Claim 24 words
The dosage formulation of claim 1 further characterized in that said micropellets have diameters in the range of about 0.5 to about 0.7 mm.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-05-05 1989-11-04 1990-05-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-05-05 1993-11-04 1994-05-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-05-05 1997-11-04 1998-05-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag